万春医药 (BYSI.O)

+ 收藏

资产负债表(万春医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年中报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 123112311231123112311231
原始币种 美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见2,922,000.008,397,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见308,000.00559,000.00
 短期投资(元) 会员可见会员可见-会员可见-5,963,000.00
 流动资产其他项目(元) 会员可见会员可见会员可见会员可见25,347,000.00-
 流动资产合计(元) 会员可见会员可见会员可见会员可见28,577,000.0014,919,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见239,000.001,487,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见5,499,000.004,491,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见5,738,000.005,978,000.00
总资产(元) 会员可见会员可见会员可见会员可见34,315,000.0020,897,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见282,000.00656,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见295,000.002,119,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见840,000.001,772,000.00
 递延收入流动(元) -----2,001,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见会员可见9,593,000.001,639,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见11,010,000.008,187,000.00
非流动负债:
 融资租赁负债非流动(元) -会员可见会员可见会员可见307,000.003,030,000.00
 递延收入非流动(元) 会员可见会员可见会员可见会员可见27,400,000.0032,343,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见9,883,000.003,612,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见37,590,000.0038,985,000.00
总负债(元) 会员可见会员可见会员可见会员可见48,600,000.0047,172,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见4,000.004,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见373,185,000.00372,117,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-407,425,000.00-403,564,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见1,336,000.001,258,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见-32,900,000.00-30,185,000.00
 少数股东权益(元) 会员可见会员可见会员可见会员可见18,615,000.003,910,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见-14,285,000.00-26,275,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见34,315,000.0020,897,000.00
公告日期 2026-03-252025-11-122025-08-132025-05-122025-03-272024-08-29
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院